Nagumo, Y.; Kandori, S.; Kojima, T.; Hamada, K.; Nitta, S.; Chihara, I.; Shiga, M.; Negoro, H.; Mathis, B.J.; Nishiyama, H.
Whole-Blood Gene Expression Profiles Correlate with Response to Immune Checkpoint Inhibitors in Patients with Metastatic Renal Cell Carcinoma. Cancers 2022, 14, 6207.
https://doi.org/10.3390/cancers14246207
AMA Style
Nagumo Y, Kandori S, Kojima T, Hamada K, Nitta S, Chihara I, Shiga M, Negoro H, Mathis BJ, Nishiyama H.
Whole-Blood Gene Expression Profiles Correlate with Response to Immune Checkpoint Inhibitors in Patients with Metastatic Renal Cell Carcinoma. Cancers. 2022; 14(24):6207.
https://doi.org/10.3390/cancers14246207
Chicago/Turabian Style
Nagumo, Yoshiyuki, Shuya Kandori, Takahiro Kojima, Kazuki Hamada, Satoshi Nitta, Ichiro Chihara, Masanobu Shiga, Hiromitsu Negoro, Bryan J. Mathis, and Hiroyuki Nishiyama.
2022. "Whole-Blood Gene Expression Profiles Correlate with Response to Immune Checkpoint Inhibitors in Patients with Metastatic Renal Cell Carcinoma" Cancers 14, no. 24: 6207.
https://doi.org/10.3390/cancers14246207
APA Style
Nagumo, Y., Kandori, S., Kojima, T., Hamada, K., Nitta, S., Chihara, I., Shiga, M., Negoro, H., Mathis, B. J., & Nishiyama, H.
(2022). Whole-Blood Gene Expression Profiles Correlate with Response to Immune Checkpoint Inhibitors in Patients with Metastatic Renal Cell Carcinoma. Cancers, 14(24), 6207.
https://doi.org/10.3390/cancers14246207